Retia Medical, an innovator in advanced hemodynamic monitoring, today announced that it has secured $15 million in Series B funding. The financing round was led by Fresenius Medical Care Ventures with participation from a second strategic investor, Red Cedar Ventures, and existing investor, the Pritzker-Vlock Family Office. Retia Medical will use the funding to expand its commercial team and accelerate the development of its next-generation algorithms for guiding care for high-risk patients.

Retia Medical will use the funding to expand its commercial team and accelerate the development of its next-generation algorithms for guiding care for high-risk patients. Retia Medical is proud to positively impact patient care in the U.S. and internationally as more hospitals continue to incorporate the Argos Cardiac Output Monitor into their standard of care.

Retia Medical Raises $15 Million To Accelerate Commercialization Of The Argos Hemodynamic Monitor

Retia Medical Raises $15 Million To Accelerate Commercialization Of The Argos Hemodynamic Monitor

Company Info